$IPX

IperionX (NASDAQ:IPX) said April-May production fell while it updated HAMR furnace controls and tested powder types, then returned to prior levels by July. The company plans to increase furnace cycles to reach 200 metric tons per annum by year-end, expand downstream processing, and add new sintering furnaces. It also reported a Titan mineral sands feasibility study with >$800M after-tax NPV and 40% post-tax IRR.

Australia’s S&P/ASX 200 trimmed early gains, up 0.61% to 9,201.60, after Wall Street’s overnight rise. Miners led, with BHP up ~3% and Rio Tinto up ~2%, while oil stocks fell, including Woodside down ~3%. Neuren Pharmaceuticals rose ~17% on Q2 results and 2026 guidance; IperionX and Clarity Pharmaceuticals also jumped. Services PMI rose to 53.6.

Australian shares rose for a fourth session, with the S&P/ASX 200 up 0.68% to 9,208.10, led by miners (BHP, Fortescue, Rio Tinto, Mineral Resources). Oil stocks were weaker (Woodside, Origin Energy, Santos, Beach Energy). Tech gains included Block, WiseTech Global, Zip, Xero and Appen. Neuren Pharmaceuticals jumped after Q2 results and FY2026 guidance upgrade.

IperionX Limited (NASDAQ: IPX) said it plans to redomicile its ultimate parent to Texas, subject to approvals, and expects the new U.S. parent’s common stock to list directly on Nasdaq, replacing its ADS structure. The company also appointed Michael J. Loparco as an independent non-executive director effective Aug. 3, 2026.

IperionX Limited (NASDAQ:IPX) said it plans to redomicile to the U.S. by creating a Texas-incorporated parent, subject to shareholder, court, regulatory, and exchange approvals. If approved, its new U.S. parent common stock would be listed directly on Nasdaq, replacing its ADS structure. It also appointed Michael J. Loparco as an independent director.

Australia’s S&P/ASX 200 trims early losses, down 0.12% to 8,965.70. Most sectors are weaker, led by energy and stocks. Fortescue falls over 2%, while BHP is slightly up. FleetPartners shares jump over 16% on a $770m SG Fleet bid. IperionX slips ~6% after a Texas redomicile and Nasdaq listing plan. S&P Global says Australia manufacturing PMI rose to 52.0.

IperionX (ASX:IPX) said it plans to redomicile to a Texas-incorporated ultimate parent and replace its US depositary shares with common stock listed directly on Nasdaq. The change needs shareholder, court, regulatory and exchange approvals. The company says it would not alter its Atlas-Titan and US operations, and aims to broaden its US investor base and liquidity. It also appointed Michael Loparco as an independent director effective 3 Aug 2026.

The S&P/ASX 200 was down 0.2% by lunchtime after opening about 0.9% lower, with energy pressured by a drop in Brent toward the low-$80s. Origin Energy rose 3% after a prior data breach. ASX stocks also moved on FDA recall news for ResMed, Regis Healthcare’s acquisition, and updates from Vulcan, FireFly, IperionX and others.

Australia’s S&P/ASX 200 fell 0.33% to 8,947.20 and the All Ordinaries slipped 0.36% to 9,105.50. Energy and miners led declines, with Fortescue down over 2% and Woodside down more than 2%. FleetPartners rose over 16% on a $770m SG Fleet bid. IperionX fell nearly 6% after Nasdaq redomicile plans. Aussie dollar $0.704.

Avingtrans (AVG) raised about £21m via a placing of 3,309,000 new shares at 630p each, according to Yahoo Finance. The funds support expansion at its Michigan nuclear facility. Nuclear revenues are about £35m, with a target of about £90m by 2031. Shares rose 4.76% to 660p.